Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China · Delayed Price · Currency is CNY

4.240

+0.230 (5.74%)

Jun 18, 2026, 3:04 PM CST

-20.00% (1Y)

Market Cap	3.02B -21.7%
Revenue (ttm)	2.30B -9.6%
Net Income	15.87M -72.5%
EPS	0.02 -72.5%
Shares Out	753.13M
PE Ratio	190.11
Forward PE	n/a
Dividend	0.02 (0.50%)
Ex-Dividend Date	Jun 12, 2026

Volume	18,317,727
Open	3.990
Previous Close	4.010
Day's Range	3.910 - 4.330
52-Week Range	3.910 - 5.860
Beta	0.33
Analysts	Strong Buy
Price Target	12.00 (+183.02%)
Earnings Date	Aug 27, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chron... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1999

Employees 2,267

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000931

Full Company Profile

Financial Performance

In 2025, SHE:000931's revenue was 2.44 billion, a decrease of -3.52% compared to the previous year's 2.53 billion. Earnings were 47.89 million, a decrease of -10.65%.

Financial Statements